Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Rx Import Task Force Will Hold Inaugural Stakeholder Meeting March 19

Executive Summary

FDA's prescription drug importation task force will meet with consumer groups March 19 in the first of five meetings with stakeholders

You may also be interested in...



Canada-Only Import Plan “Feasible,” HHS Says: Savings Would Be “Modest”

The Bush Administration would accept a Canada-only importation program that focuses solely on high volume brands, HHS Secretary Thompson and Commerce Secretary Donald Evans indicated in a Dec. 21 letter to Congress

Canada-Only Import Plan “Feasible,” HHS Says: Savings Would Be “Modest”

The Bush Administration would accept a Canada-only importation program that focuses solely on high volume brands, HHS Secretary Thompson and Commerce Secretary Donald Evans indicated in a Dec. 21 letter to Congress

HHS Drug Importation Task Force: FDA Reps Are Crawford, Sachdev

The HHS Task Force on Drug Importation includes at least three representatives from outside FDA who are likely to be primarily concerned with protecting the pharmaceutical supply chain

UsernamePublicRestriction

Register

ID1130765

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel